- Lobbying
- Lobbying by Vanda Pharmaceuticals Inc.
Lobbying Relationship
Bills mentioned
H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Sponsor: Nita M. Lowey (D-N.Y.)
H.R.6201: Families First Coronavirus Response Act
Sponsor: Nita M. Lowey (D-N.Y.)
H.R.748: CARES Act
Sponsor: Joe Courtney (D-Conn.)
H.R.7608: State, Foreign Operations, Agriculture, Rural Development, Interior,...
Sponsor: Nita M. Lowey (D-N.Y.)
H.R.133: Consolidated Appropriations Act, 2021
Sponsor: Henry Cuellar (D-Texas)
H.R.1319: American Rescue Plan Act of 2021
Sponsor: John Yarmuth (D-Ky.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Cicely Simpson | Legislative Director, Rep. Jim Cooper; Legislative Director, Rep. Lincoln Davis. |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
Executive Office of the President (EOP)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Health & Human Services - Dept of (HHS)
U.S. House of Representatives
Executive Office of the President (EOP)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate